Role of biomaterials in prevention of in-stent restenosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24307479.
- Also identified by DOI 10.1002/jbm.b.33083.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coronary balloon angioplasty and coronary stenting are the procedures used in healing coronary artery disease. However, injury of arteries during angioplasty and stenting causes cell stimulations in tissue. Cell movement and thrombosis lead to re-narrowing of widened vessel called restenosis. Several new types of carriers and technology have been developed to suppress and/or prevent restenosis. Authors review the polymeric materials featured in drug/gene carrier systems, nanovehicles, and stent coating materials against restenosis.
Medical subject headings
- Coated Materials, Biocompatible
- Coronary Artery Disease
- Coronary Restenosis
- Stents